AstraZenca - Interviews with CEO and Key Management


LONDON, July 28, 2005 (PRIMEZONE) -- ASTRAZENECA - H2 results 2005 and appointment of CEO designate: In-depth interviews available now on www.cantos.com with Sir Tom McKillop, CEO and David Brennan, Director, EVP, North America.

-- Plus Jonathan Symonds, CFO, and Dr John Patterson, Executive Director for Development, talk through the results and pipeline (LSE:AZN) (NYSE:AZN).

This programming is available in video, audio and transcript.

It's free to view. All you need to do is register athttp://www.cantos.com.

Cantos.com is an online financial website where top management of companies address the critical issues facing their businesses.

If you would like to contact us, please email enquiries@cantos.com



            

Coordonnées